Troy Schooley, CEO of P3R, is stepping down from his role, the organization announced on Thursday. Here's his next move.
Biogen will acquire San Diego's RayThera for up to $1B, expanding its immunology pipeline with early-stage anti-inflammatory ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results